These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 627176)

  • 21. [Diagnosis of osteomyelosclerosis and osteomyelo fibrosis].
    Treske U
    Dtsch Med Wochenschr; 1970 Aug; 95(33):1689-91. PubMed ID: 5447787
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation of radiologic, histologic, and clinical findings in agnogenic myeloid metaplasia.
    Pettigrew JD; Ward HP
    Radiology; 1969 Sep; 93(3):541-8. PubMed ID: 5822732
    [No Abstract]   [Full Text] [Related]  

  • 23. Linear profile scanning of marrow in myelofibrosis.
    Raich PC; Sorenson JA; Tyson IB; Korst DR
    J Reticuloendothel Soc; 1974 Nov; 16(5):282-8. PubMed ID: 4443980
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic relevance of cytogenetic abnormalities in primary myelofibrosis: comparison of recent reports from Japan, the Mayo Clinic and MD Anderson Cancer Center.
    Tefferi A
    Eur J Haematol; 2009 Oct; 83(4):290-1. PubMed ID: 19558507
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and molecular genetic characterization of myelofibrosis.
    Hobbs GS; Rampal RK
    Curr Opin Hematol; 2015 Mar; 22(2):177-83. PubMed ID: 25635755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative clinical-cytological analysis of chronic myeloleukemia and primary myelofibrosis].
    Zakharova AV; Kilmova NF; Cherntsova TA
    Probl Gematol Pereliv Krovi; 1967 Aug; 12(8):15-20. PubMed ID: 5260220
    [No Abstract]   [Full Text] [Related]  

  • 27. Constitutional trisomy 8 mosaicism in primary myelofibrosis: relevance to clinical practice and warning for trisomy 8 studies.
    Maserati E; Pressato B; Valli R; Patitucci F; Lo Curto F; Pasquali F; Minelli A; Danesino C; Marchetti M; Barosi G
    Cancer Genet Cytogenet; 2007 Nov; 179(1):79-81. PubMed ID: 17981220
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrathoracic extramedullary hematopoiesis: appearance on 99mTc sulfur colloid marrow scan.
    Bronn LJ; Paquelet JR; Tetalman MR
    AJR Am J Roentgenol; 1980 Jun; 134(6):1254-5. PubMed ID: 6770640
    [No Abstract]   [Full Text] [Related]  

  • 29. Technetium-99m as a label for erythrocytes.
    Fischer J; Wolf R; Leon A
    J Nucl Med; 1967 Mar; 8(3):229-32. PubMed ID: 6024134
    [No Abstract]   [Full Text] [Related]  

  • 30. The Argonne National Laboratory 60 inch cyclotron.
    Friedman A
    Prog Nucl Med; 1978; 4():132-9. PubMed ID: 628771
    [No Abstract]   [Full Text] [Related]  

  • 31. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
    Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
    Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neutrophilic myelofibrosis; a case report].
    Okamoto R; Harano H; Tamura T; Tanabe J; Fujita H; Fukawa H; Kanamori H; Matsuźaki M; Motomura S; Mohri H
    Rinsho Ketsueki; 1993 Aug; 34(8):957-61. PubMed ID: 8411651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of myelofibrosis with myeloid metaplasia with JAK2(V617F) mutation who developed fibrous tumours in multiple organs.
    Tabuchi T; Ohashi H; Fukami S; Susaki N; Kunishima S; Yokozawa T; Nagai H; Moritani S; Ichihara S; Saito H; Hamaguchi M
    Eur J Haematol; 2006 Sep; 77(3):264-6. PubMed ID: 16923114
    [No Abstract]   [Full Text] [Related]  

  • 34. [Reaming of the bone marrow in osteomyelosclerosis. Attempt at restoring normal erythropoiesis].
    Oberling F; Lang JM; Giron C; Babin S; Eber M; Methlin G; Roger S
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(1):250-2. PubMed ID: 896454
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.
    Alchalby H; Lioznov M; Fritzsche-Friedland U; Badbaran A; Zabelina T; Bacher U; Stübig T; Ayuk FA; Zander AR; Kröger N
    Bone Marrow Transplant; 2012 Jan; 47(1):143-5. PubMed ID: 21358677
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance of spleen pickup of radioactive gold-198.
    Verdon TA; Barrett O; Panettiere F
    J Nucl Med; 1967 May; 8(5):402. PubMed ID: 5230984
    [No Abstract]   [Full Text] [Related]  

  • 37. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis.
    Bornhäuser M; Mohr B; Oelschlaegel U; Bornhäuser P; Jacki S; Ehninger G; Thiede C
    Leukemia; 2007 Aug; 21(8):1824-6. PubMed ID: 17476275
    [No Abstract]   [Full Text] [Related]  

  • 39. An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation.
    Maia RC; Bonamino MH; Robaina MC; Amaral N; Bonecker S; Zalcberg IR; Klumb CE
    Blood Cells Mol Dis; 2015 Dec; 55(4):347-50. PubMed ID: 26460258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis.
    Guglielmelli P; Biamonte F; Spolverini A; Pieri L; Isgrò A; Antonioli E; Pancrazzi A; Bosi A; Barosi G; Vannucchi AM
    Leukemia; 2010 Aug; 24(8):1533-7. PubMed ID: 20520633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.